BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37566756)

  • 21. Genotype-phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4
    Zmajkovicova K; Pawar S; Maier-Munsa S; Maierhofer B; Wiest I; Skerlj R; Taveras AG; Badarau A
    Genes Immun; 2022 Sep; 23(6):196-204. PubMed ID: 36089616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics on a WHIM.
    Al Ustwani O; Kurzrock R; Wetzler M
    Br J Haematol; 2014 Jan; 164(1):15-23. PubMed ID: 24111611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent CXCR4 sequence variation in a girl with WHIM syndrome.
    Alapi K; Erdos M; Kovács G; Maródi L
    Eur J Haematol; 2007 Jan; 78(1):86-8. PubMed ID: 17087743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary immunodeficiencies appearing as combined lymphopenia, neutropenia, and monocytopenia.
    Dotta L; Badolato R
    Immunol Lett; 2014 Oct; 161(2):222-5. PubMed ID: 24316408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WHIM Syndrome With a Novel CXCR4 Variant in a Korean Child.
    Shin DW; Park SN; Kim SM; Im K; Kim JA; Hong KT; Choi JY; Hong CR; Park KD; Shin HY; Kang HJ; Kim HK; Lee DS
    Ann Lab Med; 2017 Sep; 37(5):446-449. PubMed ID: 28643496
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-Term Outcome of WHIM Syndrome in 18 Patients: High Risk of Lung Disease and HPV-Related Malignancies.
    Dotta L; Notarangelo LD; Moratto D; Kumar R; Porta F; Soresina A; Lougaris V; Plebani A; Smith CIE; Norlin AC; Gòmez Raccio AC; Bubanska E; Bertolini P; Amendola G; Visentini M; Fiorilli M; Venuti A; Badolato R
    J Allergy Clin Immunol Pract; 2019; 7(5):1568-1577. PubMed ID: 30716504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome.
    Laberko A; Deordieva E; Krivan G; Goda V; Bhar S; Kawahara Y; Rao K; Worth A; McDermott DH; Balashov D; Maschan A; Shcherbina A
    J Clin Immunol; 2022 Jan; 42(1):171-182. PubMed ID: 34697698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and genetic diagnosis of warts, hypogammaglobulinemia, infections, and myelokathexis syndrome in 10 patients.
    Tassone L; Notarangelo LD; Bonomi V; Savoldi G; Sensi A; Soresina A; Smith CI; Porta F; Plebani A; Notarangelo LD; Badolato R
    J Allergy Clin Immunol; 2009 May; 123(5):1170-3, 1173.e1-3. PubMed ID: 19321197
    [No Abstract]   [Full Text] [Related]  

  • 29. WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4.
    Kawai T; Choi U; Cardwell L; DeRavin SS; Naumann N; Whiting-Theobald NL; Linton GF; Moon J; Murphy PM; Malech HL
    Blood; 2007 Jan; 109(1):78-84. PubMed ID: 16946301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced function with decreased internalization of carboxy-terminus truncated CXCR4 responsible for WHIM syndrome.
    Kawai T; Choi U; Whiting-Theobald NL; Linton GF; Brenner S; Sechler JM; Murphy PM; Malech HL
    Exp Hematol; 2005 Apr; 33(4):460-8. PubMed ID: 15781337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebellar involvement in warts Hypogammaglobulinemia immunodeficiency myelokathexis patients: neuroimaging and clinical findings.
    Galli J; Pinelli L; Micheletti S; Palumbo G; Notarangelo LD; Lougaris V; Dotta L; Fazzi E; Badolato R
    Orphanet J Rare Dis; 2019 Feb; 14(1):61. PubMed ID: 30819232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCL12/CXCR4-axis dysfunctions: Markers of the rare immunodeficiency disorder WHIM syndrome.
    Bachelerie F
    Dis Markers; 2010; 29(3-4):189-98. PubMed ID: 21178277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Family studies of warts, hypogammaglobulinemia, immunodeficiency, myelokathexis syndrome.
    Dale DC; Dick E; Kelley M; Makaryan V; Connelly J; Bolyard AA
    Curr Opin Hematol; 2020 Jan; 27(1):11-17. PubMed ID: 31652152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry.
    Beaussant Cohen S; Fenneteau O; Plouvier E; Rohrlich PS; Daltroff G; Plantier I; Dupuy A; Kerob D; Beaupain B; Bordigoni P; Fouyssac F; Delezoide AL; Devouassoux G; Nicolas JF; Bensaid P; Bertrand Y; Balabanian K; Chantelot CB; Bachelerie F; Donadieu J
    Orphanet J Rare Dis; 2012 Sep; 7():71. PubMed ID: 23009155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease.
    Hernandez PA; Gorlin RJ; Lukens JN; Taniuchi S; Bohinjec J; Francois F; Klotman ME; Diaz GA
    Nat Genet; 2003 May; 34(1):70-4. PubMed ID: 12692554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling.
    Balabanian K; Levoye A; Klemm L; Lagane B; Hermine O; Harriague J; Baleux F; Arenzana-Seisdedos F; Bachelerie F
    J Clin Invest; 2008 Mar; 118(3):1074-84. PubMed ID: 18274673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse.
    Kallikourdis M; Trovato AE; Anselmi F; Sarukhan A; Roselli G; Tassone L; Badolato R; Viola A
    Blood; 2013 Aug; 122(5):666-73. PubMed ID: 23794067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plerixafor on a WHIM - Promise or Fantasy of a New CXCR4 Inhibitor for This Rare, but Important Syndrome?
    Merati N; Sivachandran S; Jfri A; Ben-Shoshan M; Vinh DC; Popradi G; Litvinov IV
    Skin Therapy Lett; 2022 Mar; 27(2):1-5. PubMed ID: 35385630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oligoclonality, impaired class switch and B-cell memory responses in WHIM syndrome.
    Mc Guire PJ; Cunningham-Rundles C; Ochs H; Diaz GA
    Clin Immunol; 2010 Jun; 135(3):412-21. PubMed ID: 20226738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome.
    Gulino AV; Moratto D; Sozzani S; Cavadini P; Otero K; Tassone L; Imberti L; Pirovano S; Notarangelo LD; Soresina R; Mazzolari E; Nelson DL; Notarangelo LD; Badolato R
    Blood; 2004 Jul; 104(2):444-52. PubMed ID: 15026312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.